What is the current plasma fraction market size?

The plasma fraction market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the plasma fraction market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the plasma fraction market?

Key drivers include rising plasma collection and growing demand for life-saving therapies.

What are the major challenges facing the plasma fraction market?

Challenges include stringent regulations, high production costs, and limited plasma supply.

Which regions are leading the plasma fraction market?

North America and Europe are regional leaders, driven by well-established healthcare systems.

Who are the top companies in the plasma fraction market?

Top companies include Grifols, CSL, and Octapharma, which dominate the global market share.

What future opportunities exist in the plasma fraction market?

Future opportunities include emerging markets, new product developments, and innovative technologies.

How is technology impacting the plasma fraction market?

Technology is improving plasma collection, testing, and manufacturing processes, enhancing overall efficiency.

What is the current regulatory landscape for the plasma fraction market?

The regulatory landscape is complex, with strict guidelines from agencies like the FDA and EMA.

What is the future outlook for the plasma fraction market?

The future outlook is positive, with growing demand and advancements in technology driving growth.

plasma fraction Market Growth Drivers & Forecast 2033

plasma fraction by Application (Hospital, Retail Pharmacy, Other), by Types (Immune Globulin, Coagulation Factor, Albumin, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

plasma fraction Market Overview

The plasma fraction market refers to the industry involved in the production and distribution of plasma-derived therapies, which are essential for treating various medical conditions. As the plasma fraction market size continues to evolve, understanding its growth outlook, market forecast, and industry expansion is crucial for stakeholders. The scope of this market encompasses the development, manufacturing, and commercialization of plasma-derived products, including immunoglobulins, clotting factors, and albumin. According to recent estimates, the current plasma fraction market size is approximately $26.5 billion. The market is expected to witness a significant growth forecast, with a compound annual growth rate (CAGR) of around 7-8% during the forecast period, driven by increasing demand for plasma-derived therapies, advancements in technology, and rising healthcare expenditure.

Loading chart…

Several key forces are shaping the plasma fraction industry, including technology shifts towards more efficient plasma collection and processing methods, regulations governing the safety and quality of plasma-derived products, and consumer behavior driven by increasing awareness of rare and orphan diseases. The largest region in the plasma fraction market is currently North America, while the fastest-growing region is expected to be the Asia-Pacific region, driven by rising healthcare infrastructure and growing demand for plasma-derived therapies. As the market continues to expand, understanding these trends and dynamics will be essential for stakeholders to navigate the plasma fraction market and capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	4.01 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Baxter; Octapharma; Biotest; CSL Behring; Grifols; Kedrion; LFB; Chinese Biological Products; Shanghai RAAS Blood Products
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The plasma fraction market is poised for significant growth, driven by increasing demand for life-saving therapies and rising awareness about the importance of plasma-derived products. The plasma fraction market size is expected to expand substantially during the forecast period, driven by advances in technology and improvements in plasma collection and fractionation processes.

Growth Drivers2 items

Increasing prevalence of rare and serious diseases, such as hemophilia and immunodeficiency disorders, is driving demand for plasma-derived therapies, thereby fueling the growth forecast of the plasma fraction market.

Advances in technology, such as improved plasma fractionation techniques and more efficient purification methods, are enabling the production of higher-quality plasma-derived products, which is expected to contribute to the plasma fraction market size expansion.

Restraints2 items

Stringent regulatory requirements and high costs associated with plasma collection, testing, and fractionation are limiting the growth forecast of the plasma fraction market, particularly for smaller players.

Fluctuations in plasma supply and demand, driven by factors such as changes in donor demographics and shifts in therapeutic demand, can impact the stability of the plasma fraction market and hinder its expansion.

Opportunities2 items

Emerging markets, particularly in Asia and Latin America, offer significant opportunities for plasma fraction market players, driven by growing demand for plasma-derived therapies and increasing investments in healthcare infrastructure.

The development of new plasma-derived products, such as therapies for rare diseases, is expected to drive innovation and growth forecast in the plasma fraction market, attracting new players and investments.

Challenges2 items

Ensuring the safety and quality of plasma-derived products, while maintaining a stable and sufficient supply, is a significant challenge facing plasma fraction market players, requiring ongoing investments in testing, validation, and quality control.

Managing the complex global supply chain, including plasma collection, fractionation, and distribution, while complying with varying regulatory requirements, is a major challenge for plasma fraction market players, impacting their ability to expand and maintain a competitive edge.

Market Segmentation

Loading chart…

The plasma fraction market can be segmented based on Application, which includes various therapeutic areas such as hemophilia, immune disorders, and critical care. This segmentation contributes to the overall plasma fraction market size by highlighting the specific needs of different patient populations and the corresponding demand for plasma-derived therapies. Understanding the plasma fraction segmentation by application is crucial for market players to develop targeted strategies and products.

Another key segmentation category is Types, which encompasses various subtypes of plasma fractions, including albumin, immunoglobulins, and coagulation factors. Each subtype has distinct characteristics, production processes, and applications, contributing to the overall market size. Analyzing the market taxonomy of plasma fractions by type and subtype enables stakeholders to identify opportunities, challenges, and trends in specific areas of the market, ultimately informing business decisions and investment strategies.

plasma fraction Segmentation Breakdown9 items

Application

Hospital

Retail Pharmacy

Other

Types

Immune Globulin

Coagulation Factor

Albumin

Other

Regional Insights

Loading chart…

The plasma fraction market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market, driven by factors such as high adoption rates of plasma fractionation products, favorable policies and investments in the healthcare sector, and a well-established infrastructure.

The fastest-growing region is expected to be Asia Pacific, driven by key drivers such as increasing demographics and ecosystem maturity, rising adoption of plasma-derived therapies, and growing investments in the healthcare sector. The region is anticipated to account for around 30% of the global plasma fraction market.

In Europe, key drivers include a mature ecosystem, high adoption rates of plasma fractionation products, and favorable policies. Latin America and Middle East & Africa are also expected to contribute to the regional forecast, driven by growing demographics and increasing investments in the healthcare sector.

Competitive Landscape

The plasma fraction market is moderately consolidated, with a mix of global players and local/regional companies. The plasma fraction competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and regulatory approvals, while local companies compete on pricing and distribution.

Companies in the plasma fraction market employ various strategies, including M&A, partnerships, product launches, expansion, R&D, and localization, to differentiate themselves. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To stay competitive, companies must focus on technology, service model, channel strength, customization, and cost advantages. Key players in the market are:

Baxter: regional expansion

Octapharma: vertical integration

Biotest: premium pricing

CSL Behring: innovation pipeline

Grifols: local manufacturing

Kedrion: OEM tie-ups

Key plasma fraction Companies9 items

Baxter

Octapharma

Biotest

CSL Behring

Grifols

Kedrion

LFB

Chinese Biological Products

Shanghai RAAS Blood Products

Market Ecosystem

The plasma fraction ecosystem spans multiple stages, from upstream raw material suppliers to midstream manufacturers and downstream distributors, ultimately serving various end-user segments. This complex value chain analysis involves numerous participants, each contributing to the creation and capture of value within the plasma fraction ecosystem.

Raw material suppliers — provide source plasma

Technology providers — develop fractionation equipment

OEMs/manufacturers — produce plasma fraction products

Distributors/channel partners — deliver products to end users

Service providers/after-sales — offer maintenance and support

Regulators/standards bodies — establish and enforce industry standards

End users/buyers — purchase and utilize plasma fraction products

Value flows through the plasma fraction ecosystem as participants interact and exchange goods, services, and information. Control points, such as regulatory approvals and industry standards, influence adoption and create dependency risks. Switching costs and partnerships can also impact the ecosystem, with participants seeking to minimize risks and maximize value. Furthermore, the plasma fraction ecosystem may differ by region due to varying regulatory environments and market demands, leading to distinct dynamics and challenges in different areas.

Recent Industry Insights

The plasma fraction industry has witnessed significant developments over the last 12-18 months, shaping the plasma fraction industry trends. Recent partnerships, such as collaborations between pharmaceutical companies and research institutions, have accelerated innovation in the sector. Notable mergers and acquisitions have also taken place, leading to consolidation and expansion of product portfolios. Furthermore, companies have launched new products and technologies, enhancing the industry's capabilities and catering to evolving consumer needs.

Additionally, regulatory changes have influenced the industry's landscape, with updated guidelines and standards impacting manufacturing processes and product quality. Shifts in consumer and enterprise trends have driven demand for certain plasma-derived products, while funding rounds and expansions have enabled companies to invest in research and development, ultimately driving growth in the plasma fraction market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the plasma fraction market. The market attractiveness is high due to increasing demand for plasma-derived therapies. The competitive intensity is moderate, with key players investing in research and development. The long-term outlook for the plasma fraction market outlook is positive, driven by growing patient populations and advancements in technology. The innovation landscape is evolving, with a focus on improving yields and reducing costs.

The demand-supply balance is stable, with manufacturers working to meet growing demand. However, key risk factors include regulatory changes and supply chain disruptions. Overall, the plasma fraction market is poised for growth, and stakeholders must stay informed about the latest trends and developments to make informed decisions.

11 items

1. Executive Summary

2. plasma fraction Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global plasma fraction Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global plasma fraction Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Retail Pharmacy

6.1.3. Other

6.2. Global plasma fraction Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Immune Globulin

6.2.2. Coagulation Factor

6.2.3. Albumin

6.2.4. Other

6.3. Global plasma fraction Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global plasma fraction Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global plasma fraction Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global plasma fraction Market Competition by Key Manufacturers

8.1. Global plasma fraction Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global plasma fraction: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Baxter

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Octapharma

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Biotest

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. CSL Behring

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Grifols

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Kedrion

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. LFB

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Chinese Biological Products

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Shanghai RAAS Blood Products

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global plasma fraction Market

Figure 4: Global plasma fraction Market: Drivers

Figure 5: Global plasma fraction Market: Challenges

Figure 6: Global plasma fraction Market: Trends

Figure 7: Global plasma fraction Market: Opportunity

Figure 8: Global plasma fraction Market: Restraint

Figure 9: Global plasma fraction Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global plasma fraction Market Value (USD Million) By Region

Figure 15: Global plasma fraction Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global plasma fraction Market Value (USD Million) By Region

Figure 23: Global plasma fraction Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

71 items

Table 1: Market Segmentation Analysis

Table 2: Global plasma fraction Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global plasma fraction Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global plasma fraction Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global plasma fraction Market Value (USD Million) By Region

Table 10: Global plasma fraction Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global plasma fraction Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global plasma fraction Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global plasma fraction Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Baxter Basic Information And Sales Area

Table 31: Baxter. Products Portfolio

Table 32: Octapharma Basic Information And Sales Area

Table 33: Octapharma. Products Portfolio

Table 34: Biotest Basic Information And Sales Area

Table 35: Biotest. Products Portfolio

Table 36: CSL Behring Basic Information And Sales Area

Table 37: CSL Behring. Products Portfolio

Table 38: Grifols Basic Information And Sales Area

Table 39: Grifols. Products Portfolio

Table 40: Kedrion Basic Information And Sales Area

Table 41: Kedrion. Products Portfolio

Table 42: LFB Basic Information And Sales Area

Table 43: LFB. Products Portfolio

Table 44: Chinese Biological Products Basic Information And Sales Area

Table 45: Chinese Biological Products. Products Portfolio

Table 46: Shanghai RAAS Blood Products Basic Information And Sales Area

Table 47: Shanghai RAAS Blood Products. Products Portfolio

Table 48: Global Market Value (USD Million) (2025-2032) By Application

Table 49: Global Market Share (%) By Application (2032)

Table 50: Global Market Value (USD Million) (2025-2032) By Types

Table 51: Global Market Share (%) By Types (2032)

Table 52: Global plasma fraction Market Value (USD Million) By Region

Table 53: Global plasma fraction Market Share (%) By Region (2025-2032)

Table 54: North America Market Value (USD Million) (2025-2032) By Country

Table 55: North America Market Value (USD Million) (2025-2032) By Application

Table 56: North America Market Value (USD Million) (2025-2032) By Types

Table 57: Europe Market Value (USD Million) (2025-2032) By Country

Table 58: Europe Market Value (USD Million) (2025-2032) By Application

Table 59: Europe Market Value (USD Million) (2025-2032) By Types

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 61: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 63: South America Market Value (USD Million) (2025-2032) By Country

Table 64: South America Market Value (USD Million) (2025-2032) By Application

Table 65: South America Market Value (USD Million) (2025-2032) By Types

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 67: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 69: Research Programs/Design For This Report

Table 70: Key Data Information From Secondary Sources

Table 71: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

plasma fraction Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	4.01 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Baxter; Octapharma; Biotest; CSL Behring; Grifols; Kedrion; LFB; Chinese Biological Products; Shanghai RAAS Blood Products
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

plasma fraction Segmentation Breakdown9 items

Application

Hospital

Retail Pharmacy

Other

Types

Immune Globulin

Coagulation Factor

Albumin

Other

Regional Insights

Loading chart…

Competitive Landscape

Baxter: regional expansion

Octapharma: vertical integration

Biotest: premium pricing

CSL Behring: innovation pipeline

Grifols: local manufacturing

Kedrion: OEM tie-ups

Key plasma fraction Companies9 items

Baxter

Octapharma

Biotest

CSL Behring

Grifols

Kedrion

LFB

Chinese Biological Products

Shanghai RAAS Blood Products

Market Ecosystem

Raw material suppliers — provide source plasma

Technology providers — develop fractionation equipment

OEMs/manufacturers — produce plasma fraction products

Distributors/channel partners — deliver products to end users

Service providers/after-sales — offer maintenance and support

Regulators/standards bodies — establish and enforce industry standards

End users/buyers — purchase and utilize plasma fraction products

Recent Industry Insights

Analyst Overview

Table of Contents